AMGEN INC (AMGN) vs PFIZER INC (PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | AMGN | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $36.75B | $62.58B |
| Revenue growth (YoY) | ▲ 10.0% | ▼ 1.6% |
| Net income | $7.71B | $7.77B |
| Gross margin | 67.2% | 74.3% |
| Diluted EPS | $14.23 | $1.36 |
| Insider net (6 mo) | +15.3K sh • 5 sells • 0 buys | +109.6K sh • 2 sells • 3 buys |
| Institutional owners | 46 | 43 |
| Institutional value held | $113.58B | $61.91B |
| Next earnings (est.) | Nov 3, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AMGEN INC (AMGN)
Amgen Inc. is a global biotechnology company, incorporated in California in 1980 and reincorporated in Delaware in 1987, that discovers, develops, manufactures, and delivers innovative medicines targeting areas of high unmet medical need, operating as a… Read more →
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across… Read more →
Source: SEC EDGAR.